Psychiatry and Neurology, Neurology · Ocala, FL
NPI
1366411514
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2237 SW 19th Avenue Rd Ste 101
Ocala, FL, 34471
Phone (352) 867-9877
Groups this clinician bills Medicare through
Medicare paid, 2024
$681K
5,774 services
Medicare patients, 2024
793
Average age 72
Drug cost, 2024
$7.9M
8,741 prescriptions
Company payments, 2025
$127K
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lance Y Kim was code J1885 (injection, ketorolac tromethamine, per 15 mg), 1,136 times for 165 patients. In total Lance Y Kim billed 5,774 services in 50 codes, and Medicare paid $681K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 1,136 | 165 | $0.52 | $592 |
| 99214 Office E&M - Established | Office | 638 | 463 | $86.93 | $55K |
| 95886 Electrical Nerve Conductivity | Office | 513 | 238 | $68.10 | $35K |
| 70551 MRI/MRA - Head and Neck | Office | 318 | 239 | $139.26 | $44K |
| 99204 Office E&M - New | Office | 313 | 313 | $114.14 | $36K |
| 95810 Sleep Study | Office | 260 | 259 | $438.27 | $114K |
| 95819 Neurologic | Office | 256 | 254 | $313.51 | $80K |
| 99213 Office E&M - Established | Office | 243 | 237 | $63.88 | $16K |
| 95811 Sleep Study | Office | 216 | 216 | $461.80 | $100K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 202 | 202 | $133.12 | $27K |
| 93886 Ultrasound - Nonspecific | Office | 202 | 202 | $191.00 | $39K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 199 | 122 | $0.10 | $20.58 |
| 64445 Nerve Block Injection - Back | Office | 171 | 117 | $161.55 | $28K |
| 95908 Electrical Nerve Conductivity | Office | 163 | 163 | $78.00 | $13K |
| 64415 Musculoskeletal | Office | 106 | 72 | $128.22 | $14K |
By year: 2022 $678K for 5,671 services; 2023 $708K for 6,015 services; 2024 $681K for 5,774 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lance Y Kim prescribed most often to Medicare patients was Donepezil Hcl, with 577 prescriptions and refills. In total Lance Y Kim wrote 8,741 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 577 | 1,240 | 223 | $5,672 |
| Topiramate Generic | 515 | 1,046 | 208 | $3,895 |
| Rizatriptan Rizatriptan Benzoate | 449 | 493 | 173 | $8,504 |
| Memantine Hcl Generic | 393 | 845 | 144 | $11K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 377 | 838 | 143 | $6,742 |
| Gabapentin Generic | 373 | 711 | 140 | $5,992 |
| Amitriptyline Hcl Generic | 355 | 600 | 151 | $3,500 |
| Clonazepam Generic | 308 | 368 | 71 | $1,796 |
| Emgality Pen Galcanezumab-Gnlm | 308 | 352 | 71 | $241K |
| Citalopram Hbr Citalopram Hydrobromide | 167 | 371 | 63 | $1,150 |
| Levetiracetam Generic | 163 | 304 | 47 | $5,948 |
| Nurtec Odt Rimegepant Sulfate | 163 | 169 | 44 | $206K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 156 | 217 | 34 | $157K |
| Modafinil Generic | 150 | 220 | 39 | $39K |
| Ropinirole Hcl Generic | 148 | 327 | 58 | $2,538 |
Brand drugs: 1,998 claims; generic drugs: 6,715 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lance Y Kim $127K ($127K in general payments such as food, travel and fees) from 38 companies. The largest payer was TG Therapeutics, Inc. with $34K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 33 | $34K |
| Abbvie Inc. ABBV | 49 | $27K |
| Lundbeck LLC | 57 | $20K |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $14K |
| ACADIA Pharmaceuticals Inc ACAD | 21 | $10K |
| SK Life Science, Inc. | 31 | $7,902 |
| C2N Diagnostics, LLC | 16 | $5,428 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $3,224 |
| Teva Pharmaceuticals USA, Inc. TEVA | 32 | $712 |
| UCB, Inc. UCB.BR | 11 | $485 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.